Arca
Skip to content
Tools
Tools

Ferriprotoporphyrin IX

Small molecule in Plasmodium falciparum that 10 drugs act on.

  • Drugs that act on it: 10
  • Approved: 9
  • In phases 1 to 3: 1
  • Sponsors: 7

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 10

Approved9

  • Hydroxychloroquine
  • Chloroquine
  • Artemether
  • Lumefantrine
  • Artenimol
  • Halofantrine
  • Amodiaquine
  • Quinine
  • Mefloquine

Phase 31

  • Piperaquine

Phase 20

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 9 of 10 act as: Ferriprotoporphyrin IX inhibitor; the rest name their own mechanism.
      HydroxychloroquineApprovedADVANZ PHARMASmall moleculeInhibitor101
      ChloroquineApproved—Small moleculeInhibitor73
      ArtemetherApprovedNovartis PharmaceuticalsSmall moleculeInhibitor16
      LumefantrineApprovedNovartis PharmaceuticalsSmall moleculeInhibitor16
      ArtenimolApprovedFrantz Viral Therapeutics, LLCSmall moleculeBinding agentFerriprotoporphyrin IX binding agent10
      HalofantrineApprovedGSKSmall moleculeInhibitor6
      AmodiaquineApprovedPfizerSmall moleculeInhibitor4
      QuinineBoxed warningApprovedSun Pharmaceutical IndustriesSmall moleculeInhibitor3
      MefloquineBoxed warningApprovedUS Army Walter ReedSmall moleculeInhibitor2
      PiperaquinePhase 3—Small moleculeInhibitor20

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 43 in all, from ClinicalTrials.gov.
      Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging ClocksHydroxychloroquine, ChloroquineEarly phase 1Enrolling by invitationFrontiers in Bioscience Research Institute and AgingOct 22, 2026
      Repurposing Mefloquine for Pancreatic Cancer TreatmentMefloquinePhase 1Not yet recruitingUniversity of FloridaOct 15, 2026
      Exploratory Study on the Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Moderate to Severe Primary Sjögren's SyndromeHydroxychloroquinePhase 2Not yet recruitingBeijing Tongren HospitalOct 1, 2026
      Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung DiseaseHydroxychloroquine—RecruitingPeking University People's HospitalSep 28, 2026
      Ethiopian Antimalarial Therapeutic Efficacy Study 2026Artemether, Chloroquine, Lumefantrine—Not yet recruitingEthiopian Public Health InstituteSep 25, 2026
      Tafenoquine Drug Levels in Small ChildrenChloroquinePhase 2Not yet recruitingUniversity of OxfordSep 22, 2026
      ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months.Hydroxychloroquine, ChloroquinePhase 3Not yet recruitingStarship Child Health, Te Toka Tumai AucklandSep 21, 2026
      Pilot Study of Hydroxychloroquine for the Treatment of AIMSSHydroxychloroquine, ChloroquinePhase 2RecruitingIndiana UniversitySep 17, 2026
      Hydrochloroquinine & Decitabine With Venetoclax in AMLHydroxychloroquine, ChloroquinePhase 1Not yet recruitingRutgers, The State University of New JerseySep 10, 2026
      Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)Artemether, LumefantrinePhase 2RecruitingNovartis PharmaceuticalsSep 10, 2026
      CapeOx Combined With Anti-PD1 Antibody Plus Dihydroartemisinin as Neoadjuvant or Conversion Therapy for Microsatellite Stable Locally Advanced and Metastatic Colorectal CancerArtenimolPhase 2Active, not recruitingShanghai Changzheng HospitalSep 3, 2026
      OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan SchoolchildrenPiperaquinePhase 3Not yet recruitingIndiana UniversitySep 1, 2026
      Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant MelanomaHydroxychloroquine, ChloroquinePhase 2RecruitingSun Yat-sen UniversityAug 6, 2026
      The Effect of Nicorandil on Rheumatoid Arthritis PatientsHydroxychloroquine, ChloroquinePhase 2 / Phase 3RecruitingAin Shams UniversityJul 28, 2026
      Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated MalariaArtemether, LumefantrinePhase 4Not yet recruitingNovartis PharmaceuticalsJul 20, 2026
      Dihydroartemisinin for MAFLDArtenimolPhase 1 / Phase 2RecruitingThe First Affiliated Hospital with Nanjing Medical UniversityJul 1, 2026
      Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic AbnormalitiesQuininePhase 2RecruitingAmplexd Therapeutics, Inc.May 7, 2026
      Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated MalariaArtemether, LumefantrinePhase 2RecruitingVictoria Biomedical Research InstituteApr 30, 2026
      A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus ErythematosusArtenimolPhase 2Not yet recruitingKunming Pharmaceuticals, Inc.Apr 30, 2026
      Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium VivaxArtemether, Lumefantrine, PiperaquineNot applicableNot yet recruitingWalter Reed Army Institute of Research (WRAIR)Apr 16, 2026
      Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture HeadacheHalofantrineNot applicableRecruitingTanta UniversityApr 7, 2026
      RSV Vaccination to Reduce Recurrent AECOPDHalofantrinePhase 4Not yet recruitingChinese University of Hong KongApr 2, 2026
      A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy AdultsPiperaquinePhase 1Not yet recruitingUniversity of OxfordMar 13, 2026
      Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated MalariaArtemether, Lumefantrine, PiperaquinePhase 4Not yet recruitingCurtin UniversityFeb 11, 2026
      Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of GhanaPiperaquineNot applicableRecruitingNoguchi Memorial Institute for Medical ResearchFeb 5, 2026
      Perennial Malaria Chemoprevention in the Malaria Vaccine EraAmodiaquine, PiperaquinePhase 4Not yet recruitingStanford UniversityJan 7, 2026
      MDA and Targeted Control Against Plasmodium Carriage in the SahelPiperaquineNot applicableActive, not recruitingInstitut de Recherche pour le DeveloppementDec 15, 2025
      Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community TransmissionPiperaquinePhase 4RecruitingUniversity of California, San FranciscoNov 24, 2025
      Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)HalofantrinePhase 3Active, not recruitingUniversity Health Network, TorontoNov 21, 2025
      Efficacy of Dihydroartemisinin for Treating Acne VulgarisArtenimolEarly phase 1RecruitingShanghai Zhongshan HospitalJun 5, 2025
      OPTImizing Malaria And HIV Treatment in a Shifting Landscape in AfricaAmodiaquine, Artemether, LumefantrinePhase 4RecruitingYale UniversityMay 13, 2025
      Safety of Antimalarials in the FIRst trimEsterQuinine, Artemether, LumefantrinePhase 3RecruitingLiverpool School of Tropical MedicineMay 8, 2025
      A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy IndividualsHalofantrinePhase 1 / Phase 2RecruitingShanghai Institute Of Biological ProductsApr 17, 2025
      Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and MadagascarAmodiaquinePhase 3RecruitingLondon School of Hygiene and Tropical MedicineApr 11, 2025
      Dihydroartemisinin for the Treatment of Polycystic Ovary SyndromeArtenimolPhase 2RecruitingShanghai Zhongshan HospitalFeb 24, 2025
      Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed PeopleHalofantrinePhase 4RecruitingMedical University of ViennaNov 5, 2024
      Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, EthiopiaArtenimolPhase 3Active, not recruitingPATHJul 23, 2024
      Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative ParticipantsArtenimolPhase 2RecruitingFrantz Viral Therapeutics, LLCJan 16, 2024
      Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)ArtenimolPhase 2RecruitingFrantz Viral Therapeutics, LLCOct 10, 2023
      A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 MedicinesAmodiaquinePhase 3RecruitingUniversity of OxfordJul 19, 2023
      FocaL Mass Drug Administration for Vivax Malaria EliminationMefloquinePhase 3RecruitingUniversity of California, San FranciscoJan 19, 2023
      Dental Biofilm Control During Orthodontic TreatmentHalofantrinePhase 3Active, not recruitingUniversity of RijekaSep 8, 2022
      Taste Physiology in Obese Volunteers Before and After Bariatric SurgeryQuinineNot applicableRecruitingUniversity Hospital, Basel, SwitzerlandSep 15, 2016

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL613897, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.